General
Preferred name
IOHEXOL
Synonyms
Omnipaque ()
Omnipaque 240 ()
NSC-759636 ()
Omnipaque 180 ()
WIN 39424 ()
Oraltag ()
Omnipaque 350 ()
Omnipaque 9 ()
Omnipaque 140 ()
Iohexolum ()
Exypaque ()
WIN-39424 ()
Omnipaque 12 ()
Omnipaque 70 ()
Omnipaque 300 ()
Omnipaque 210 ()
Iohexol-d5 ()
P&D ID
PD009532
CAS
928623-33-0
66108-95-0
Tags
available
drug
Approved by
FDA
First approval
1985
Drug Status
approved
Max Phase
4.0
Drug indication
HIV infection
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Iohexol is a non-ionic, water-soluble contrast agent used as a reference marker for the determination of glomerular filtration rate (GFR) at the level of renal function. Iohexol can be used for contrast in myelography, computerized tomography (cisternography, ventriculography) and MicroCT imaging[1][2].
DESCRIPTION
Iohexol is an X-ray contrast agent containing varying concentrations of iohexol, which can be used for a variety of imaging applications.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
41
Molecular Weight
820.88
Hydrogen Bond Acceptors
9
Hydrogen Bond Donors
8
Rotatable Bonds
12
Ring Count
1
Aromatic Ring Count
1
cLogP
-1.63
TPSA
199.89
Fraction CSP3
0.53
Chiral centers
3.0
Largest ring
6.0
QED
0.11
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
Autophagy
Mitophagy
Source data
